The prediction and analysis for the worldwide and regional markets for upstream bioprocessing are covered in the research. The report presents historical data from 2019 and revenue-based forecasts for the years 2021 through 20258. (USD Million). The upstream bioprocessing market’s drivers and restraints, as well as their effects on demand over the forecast period, are covered in the study. The examination of prospects present in the global and regional markets for upstream bioprocessing is also included in the paper.
Market Size and Analysis
Rising cell line productivity has purposefully improved upstream processing performance with low cost and great process reproducibility. Upstream bioprocessing, which creates cell lines and cultivates them so that the cells can be grown by harvesting, is the initial step in the bioprocess.
According to Data Bridge Industry Research, the upstream bioprocessing market, which had a value of USD 8,391.22 million in 2021, will soar to USD 14256.78 million by 2028 and have a CAGR of 6.85% from 2022 to 2028. Along with market information like market size, growth rate, market segmentation, geographic reach, market participants, and market scenario, The Data Bridge Market Research team’s thorough expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework are also included in the market study.
Bioprocessing, another name for the manufacture of biopharmaceuticals, is a bioprocess engineering application used in the cultivation of therapeutic cells. End products from bioprocessing are very valuable and are used to accomplish certain objectives. The two different kinds of procedures used in the creation of biopharmaceuticals are upstream and downstream biopharmaceutical manufacturing.
The global upstream bioprocessing market is segmented based on product into cell culture products, filters, bags & containers, bioreactors accessories, and others. As a result of rising installations from both small- and large-scale manufacturing, the bioreactors/fermenters sector held the biggest market share in 2020. The expansion of the bioreactors/fermenters product type segment has been ascribed to technological advancements and process automation for cost-effective, legally compliant, and secure manufacturing. Due to rising demand for cell cultures with greater titer productivity to manufacture biosimilars and monoclonal antibodies, the cell culture products category is anticipated to develop at the greatest CAGR over the forecast period (mAbs).
The market is divided into three categories based on workflow: cell culture, media preparation, and cell separation. The cell culture workflow segment accounted for the biggest market share in 2020 and is anticipated to continue to rule over the coming years. The strong growth of the cell culture workflow segment has been linked to technological developments such as small-scale bioproduction using micro-bioreactors and use of bioinformatics tools, data analysis, and management solutions.
The upstream bioprocessing market is divided into in-house and outsourced segments based on mode. Because it is more affordable and has a significant number of companies with established in-house manufacturing, the in-house method of bioprocessing has the biggest market share.
Major players included in the report are GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Corning, Inc., Applikon Biotechnology, Eppendorf AG, PBS Biotech, Inc., Lonza, Boehringer Ingelheim, CellGenix GmbH, Patheon, Samsung BioLogics, JM BIOCONNECT, CMC Biologics, and Danaher Corporation.
The report segment of global upstream bioprocessing market as follows:
Global Upstream Bioprocessing Market: By Product
Bioreactors/Fermenters
Cell Culture Products
Filters
Bioreactors Accessories
Bags & Containers
Others
Global Upstream Bioprocessing Market: By Workflow
Media Preparation
Cell Culture
Cell Separation
Global Upstream Bioprocessing Market: By Mode
In-house
Outsourced
Global Upstream Bioprocessing Market: By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
